These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33674685)

  • 1. Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas.
    Merry E; Thway K; Jones RL; Huang PH
    NPJ Precis Oncol; 2021 Mar; 5(1):17. PubMed ID: 33674685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas.
    Le Guellec S; Lesluyes T; Sarot E; Valle C; Filleron T; Rochaix P; Valentin T; Pérot G; Coindre JM; Chibon F
    Ann Oncol; 2018 Aug; 29(8):1828-1835. PubMed ID: 29860427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
    Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
    Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA sequencing validation of the Complexity INdex in SARComas prognostic signature.
    Lesluyes T; Pérot G; Largeau MR; Brulard C; Lagarde P; Dapremont V; Lucchesi C; Neuville A; Terrier P; Vince-Ranchère D; Mendez-Lago M; Gut M; Gut I; Coindre JM; Chibon F
    Eur J Cancer; 2016 Apr; 57():104-11. PubMed ID: 26916546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating soft tissue sarcomas with adjuvant chemotherapy.
    Patrikidou A; Domont J; Cioffi A; Le Cesne A
    Curr Treat Options Oncol; 2011 Mar; 12(1):21-31. PubMed ID: 21384115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can DNA Methylation Profiling Classify Histologic Subtypes and Grades in Soft Tissue Sarcoma?
    Kim H; Joo MW; Yoon J; Park HS; Kim JH; Lee JH; Kim SH; Lee SK; Chung YG; Cho YJ
    Clin Orthop Relat Res; 2024 Mar; 482(6):1028-37. PubMed ID: 38517415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic research in sarcomas - current status and future opportunities.
    Burns J; Wilding CP; L Jones R; H Huang P
    Semin Cancer Biol; 2020 Apr; 61():56-70. PubMed ID: 31722230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma.
    Bertucci F; De Nonneville A; Finetti P; Perrot D; Nilbert M; Italiano A; Le Cesne A; Skubitz KM; Blay JY; Birnbaum D
    Ann Oncol; 2018 Feb; 29(2):459-465. PubMed ID: 29069276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
    Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
    Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteomic landscape of soft tissue sarcomas.
    Burns J; Wilding CP; Krasny L; Zhu X; Chadha M; Tam YB; Ps H; Mahalingam AH; Lee ATJ; Arthur A; Guljar N; Perkins E; Pankova V; Jenks A; Djabatey V; Szecsei C; McCarthy F; Ragulan C; Milighetti M; Roumeliotis TI; Crosier S; Finetti M; Choudhary JS; Judson I; Fisher C; Schuster EF; Sadanandam A; Chen TW; Williamson D; Thway K; Jones RL; Cheang MCU; Huang PH
    Nat Commun; 2023 Jun; 14(1):3834. PubMed ID: 37386008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CINSARC signature as a prognostic marker for clinical outcome in sarcomas and beyond.
    Chibon F; Lesluyes T; Valentin T; Le Guellec S
    Genes Chromosomes Cancer; 2019 Feb; 58(2):124-129. PubMed ID: 30387235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature.
    Bertucci F; Niziers V; de Nonneville A; Finetti P; Mescam L; Mir O; Italiano A; Le Cesne A; Blay JY; Ceccarelli M; Bedognetti D; Birnbaum D; Mamessier E
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grading of soft tissue sarcomas: from histological to molecular assessment.
    Neuville A; Chibon F; Coindre JM
    Pathology; 2014 Feb; 46(2):113-20. PubMed ID: 24378389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Global and Integrated Analysis of CINSARC-Associated Genetic Defects.
    Lesluyes T; Chibon F
    Cancer Res; 2020 Dec; 80(23):5282-5290. PubMed ID: 33023949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining Which Patients Are at High Risk for Recurrence of Soft Tissue Sarcoma.
    Spolverato G; Callegaro D; Gronchi A
    Curr Treat Options Oncol; 2020 May; 21(7):56. PubMed ID: 32462511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing biomarkers for soft tissue sarcomas.
    Czarnecka AM; Chmiel P; Błoński P; Rutkowski P
    Expert Rev Anticancer Ther; 2024 Jun; 24(6):407-421. PubMed ID: 38682679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity.
    Chibon F; Lagarde P; Salas S; Pérot G; Brouste V; Tirode F; Lucchesi C; de Reynies A; Kauffmann A; Bui B; Terrier P; Bonvalot S; Le Cesne A; Vince-Ranchère D; Blay JY; Collin F; Guillou L; Leroux A; Coindre JM; Aurias A
    Nat Med; 2010 Jul; 16(7):781-7. PubMed ID: 20581836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.